MILWAUKEE (PRWEB)
October 23, 2019

Hammes Company, the nation’s leading healthcare developer as ranked by Modern Healthcare’s Construction and Design Survey, celebrated the groundbreaking of the Virginia Hospital Center (VHC) expansion project on October 22. The expansion will take place in phases, first with the construction of a new 1,700-car parking garage followed by the hospital’s new 250,000-square foot, seven-story outpatient center on its Edison Street site, just north of its current campus.

Hammes Company was first engaged by VHC to complete a facility master plan to guide the hospital’s growth and expansion strategy. Hammes Company was subsequently engaged through a competitive process to provide project management services for the expansion, which includes advising on all aspects of the design, construction and occupancy planning for the new facility. The architect for the project is HDR and the construction manager is Skanska USA Building.

“The Hammes Company team has worked alongside Virginia Hospital Center and Arlington County officials since the early stages of this project to ensure a thoughtful expansion strategy was in place to best serve the hospital’s growing population well into the future,” said Michael Killian, vice president of Hammes Company Healthcare. “The groundbreaking is an exciting milestone as we move toward the construction phase of the project.”

“This will be the most significant expansion of Virginia Hospital Center’s facilities in more than 20 years,” said Charles Fletcher, Virginia Hospital Center’s vice president of support services. “We have an outstanding team in place to help us complete this transformative project over the next three years.”

About Hammes

Hammes Company has been ranked as a leading healthcare facility developer for 21 years by Modern Healthcare’s Construction and Design Survey. Hammes has managed in excess of 57 million square feet of complex new, expansion, renovation, replacement, ambulatory care and acute care projects with a value of more than $23 billion for hospitals and health systems nationwide. The company has extensive experience managing the planning, financing, development, construction, leasing and management of non-acute and acute healthcare facilities. Hammes has helped many of the nation’s leading healthcare organizations plan, implement and manage facility strategies and solutions for more than a quarter of a century. The company delivers measurable results that help healthcare providers grow while meeting the unique health and wellness needs of their communities. Headquartered in Milwaukee, Wisconsin, Hammes provides services through a network of regional offices strategically located across the United States.

Share article on social media or email:

Paula’s efforts will support and impact the lives of these young girls and their communities and help create equal opportunities for women across STEM industries. It’s a true example of how our teams advance DuPont’s commitment to diversity and inclusion.

WILMINGTON, Del. (PRWEB)
October 23, 2019

While roughly one-third of girls say they have considered a STEM career, only one-quarter actually pursue that path.(1) DuPont Nutrition & Biosciences is looking to change that statistic by creating equal opportunities across the scientific industry. Part of these efforts includes empowering its employees to drive the mission forward, and Paula Garcia Todd will do just that as a recently selected IF/THEN® ambassador of the American Association for the Advancement of Sciences (AAAS).

Garcia Todd, Global Strategic Marketing Manager, Drug Delivery Technologies, DuPont Nutrition & Biosciences, will bring her passion for science and mentoring to the next generation of STEM women through her year-long ambassadorship. As a first step, the ambassadors will connect with middle-schoolers both in person and through online platforms to serve as their personal mentor. Using the $5,000 ambassador stipend, Paula will work with teachers to create solutions to identify and access STEM corporate outreach programs like those offered through DuPont.

“Growing up in a family of engineers, I was constantly surrounded by examples of how those who worked in STEM improved the lives of others,” Garcia Todd said. “That inspiration led me to the pharmaceutical space, and as an IF/THEN® ambassador, I hope to introduce young women to the magic that happens when the impossible is met with innovative solutions.”

The IF/THEN® initiative was created by AAAS and Lyda Hill Philanthropies to empower innovators to use their firsthand experiences in the field to inspire and motivate middle-school girls to seek STEM careers. More than 100 women were selected for the initiative to serve as the first group of ambassadors based on their contributions to advance the industry; experience in communication and public engagement via media, classroom, and public programs; and their desire to impact youth.

“Paula’s efforts will support and impact the lives of these young girls and their communities and help create equal opportunities for women across STEM industries,” said Angela Strzelecki, Global Business Director, Pharma Solutions, DuPont Nutrition & Biosciences. “It’s a true example of how our teams advance DuPont’s commitment to diversity and inclusion, and I’m thrilled to see how Paula will help contribute.”

Throughout her 16 years with DuPont, and previously Dow, Garcia Todd has been an asset to driving pharmaceutical product innovation and a champion for diversity and inclusion efforts. She has contributed expertise through roles in engineering, research and development, technical support and various marketing and product management positions. In addition to her role at DuPont where she directs new product strategy and identifies pharmaceutical needs to accelerate customer growth and innovation, Garcia Todd volunteers in college environments and local communities and serves on several Boards focused on increasing STEM opportunities.

Garcia Todd and her fellow ambassadors will be celebrated for their achievements and initiated into the program at the IF/THEN® Summit in Dallas next week, where they’ll collaborate on ways to encourage, coach and influence their mentees during their yearlong commitment. In addition to these honorees, AAAS collaborates with dozens of organizations including Girl Scouts of the USA, National Geographic, Teach for America, U.S. Soccer and the World Wildlife Fund to further promote women in STEM among young girls.

DuPont also will sponsor the CPhI Worldwide ‘Women in Leadership Forum’ in early November where Strzelecki will join other industry leaders to discuss how to build a workforce where women are supported, emboldened and empowered to excel around the globe. To learn more about DuPont’s diversity and inclusion efforts, please visit: https://www.dupont.com/careers/diversity-and-inclusion.html.

About DuPont Nutrition & Biosciences

DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandhealth.com or http://www.biosciences.dupont.com.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food and worker safety. More information can be found at http://www.dupont.com.

# # #

10/23/19

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

(1) Geena Davis Institute and Lyda Hill Foundation study

Share article on social media or email:

Mindray’s TE7 Ultrasound System Crystal Series

“Through a partnership with Mindray, I have gained access to incredible life-saving technologies.” – Dr. Robert Reardon, MD of Emergency Medicine at Hennepin County Medical Center, Minnesota’s first Level 1 Trauma Center

MAHWAH, N.J. (PRWEB)
October 23, 2019

Mindray, a global developer of technologies and solutions for patient monitoring, anesthesia and ultrasound, today announced they will be attending the American College of Emergency Physicians (ACEP) 2019 Scientific Assembly to highlight their advanced cardiac capabilities. ACEP, the world’s largest emergency medicine conference, will take place from October 27-30 in Denver, Colorado. Mindray will feature live scanning and an in-booth presentation on Tissue Tracking technology by Dr. Robert Reardon, MD of Emergency Medicine at Hennepin County Medical Center, Minnesota’s first Level 1 Trauma Center. All ACEP attendees are invited to visit exhibit #221 to learn more about Mindray’s complete range of advanced emergency medicine solutions.

Over the past 20 years, ultrasound has become an integral part of emergency departments, particularly for use with patients experiencing cardiac arrest. At the ACEP Scientific Assembly, Mindray will highlight its three primary point-of-care ultrasound systems, TE7, M9 and ZS3, each of which is equipped with advanced cardiac capabilities and transesophageal echocardiography (TEE) technology.

According to the American College of Emergency Physicians, “ultrasound has been shown in cardiac arrest to accurately identify the presence or lack of intrinsic cardiac activity and in some cases the cause of arrest, including left ventricular failure, right ventricular failure, pulmonary embolism, pericardial tamponade, and hypovolemia¹.” The College also observed that TEE allows emergency physicians to continuously monitor the patient without interrupting chest compressions during a cardiac arrest¹.

Mindray’s advanced single crystal transducers with 3T technology™ allow the end-user to scan at higher frequencies without the loss of penetration, thus bringing large cart-based image resolution to the point-of-care setting. Accompanying Tissue Tracking technology with quantitative analysis allows users to monitor the displacement of cardiac tissue by tracking the speckle displacement in the image from frame to frame. This advanced technology brings quantitative cardiac dysfunction assessment tools to the bedside.

“Through a partnership with Mindray, I have gained access to incredible life-saving technologies,” says Dr. Reardon. “I am passionate about assuring that every one of my patients receives the highest quality emergency care, and Mindray’s ultrasound systems empower me to provide care above and beyond the industry standard. Their mission to put healthcare within reach is evident in all that they do to support my team and me.”

Also on display will be Mindray’s new BeneVision N-Series Patient Monitoring Platform, the first-ever patient monitoring platform to incorporate capacitive touchscreen technology across all of its monitors. Using its unique multi-gesture touch and swipe control, similar to a smart device, clinicians can cut minutes off of clinical review, analysis and charting time. Applying the same user interface across the entire suite, N-Series supports unprecedented usability and clinical proficiency. Additionally, with the clever N1 3-in-1 monitor at the core, serving as both monitor and module and with wireless capability, N1 provides gap-free monitoring from the point of admission to discharge.

Visit ACEP exhibit #221 to see all that Mindray North America can offer an emergency department.

Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, In Vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

[1] American College of Emergency Physicians. (207, April). Guidelines for the Use of Transesophageal Echocardiography (TEE) in the ED for Cardiac Arrest [Policy Statement]. Retrieved from https://www.acep.org/globalassets/new-pdfs/policy-statements/guidelines-for-the-use-of-transesophogeal-echocardiography-in-the-ed-for-cardiac-arrest.pdf

Share article on social media or email: